Reiners C, Reimann J, Schäffer R, Baum K, Becker W, Eilles C, Gerhards W, Schick F, Spiegel W, Wiedemann W
Rofo. 1984 Sep;141(3):306-13. doi: 10.1055/s-2008-1053138.
In a retrospective analysis in patients with differentiated thyroid carcinoma, the diagnostic validities of 131I whole-body scans and radioimmunologic determinations of thyroglobulin (hTg) are compared with special regard to late metastases. Metastases were found in 83 out of 311 patients with differentiated thyroid carcinoma. In two thirds of the cases, these were primary metastases while in the remaining third of the cases, metastases developed in later follow-up with a mean time of latency of 3.3 years. While about 70% of the early metastases could bei detected by 131I scintigraphy, this percentage amounted to only 40% in late metastases. With a diagnostic sensitivity of 90%, hTg-RIA was clearly superior in the detection of early as well as of late metastases. hTg was measurable, however, only in iatrogenous hypothyroidism in 4 out of 49 cases. Based on these results and an analysis of the literature, a program for follow-up of differentiated thyroid carcinoma is proposed. The hTg-RIA is thereby used as an alternative to 131I scintigraphy in the late phase of follow-up after complete ablation of any thyroid tissue.
在一项对分化型甲状腺癌患者的回顾性分析中,对131I全身扫描和甲状腺球蛋白(hTg)放射免疫测定的诊断有效性进行了比较,特别关注晚期转移情况。在311例分化型甲状腺癌患者中,有83例发现了转移。在三分之二的病例中,这些是原发性转移,而在其余三分之一的病例中,转移在后续随访中出现,平均潜伏期为3.3年。虽然约70%的早期转移可通过131I闪烁扫描检测到,但晚期转移的这一比例仅为40%。hTg放射免疫分析的诊断敏感性为90%,在检测早期和晚期转移方面明显更具优势。然而,在49例病例中,只有4例在医源性甲状腺功能减退症中可检测到hTg。基于这些结果和文献分析,提出了一个分化型甲状腺癌的随访方案。因此,在完全切除任何甲状腺组织后的随访后期,hTg放射免疫分析可作为131I闪烁扫描的替代方法。